03/22/2024
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:30 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-K/A | |
02/16/2024
4:30 PM | Cicala Peter (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/16/2024
6:30 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
6:05 AM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
| Form SC 13G/A | |
01/22/2024
11:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
01/19/2024
9:31 AM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
| Form SC 13G/A | |
|
01/12/2024
3:49 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/22/2023
11:05 AM | Cherington Charles (Filed by)
NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
| Form SC 13D/A | |
12/20/2023
3:20 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
2:24 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
| Form SC 13G | |
12/20/2023
9:05 AM | Cherington Charles (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
8:38 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Freebird Investments LLC (Reporting)
Freebird Partners LP (Reporting)
HUFF CURTIS W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:30 PM | Bristol James Arthur (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2023
7:30 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
7:34 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:30 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K/A | |
09/08/2023
5:07 AM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
| Form SC 13G/A | |
09/07/2023
4:26 PM | Cherington Charles (Filed by)
NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
| Form SC 13D/A | |
09/01/2023
4:00 PM | Clarke Dorothy J (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/28/2023
3:57 PM | NTN Buzztime (Subject)
Eterna Therapeutics Inc. (Subject)
Purchase Capital LLC (Filed by)
| Form SC 13G | |
08/25/2023
6:34 PM | Cherington Charles (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
6:00 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 424B3 | |
08/22/2023
11:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form EFFECT | |
08/02/2023
4:25 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:15 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
WAGNER RICHARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:15 PM | BINDER BRANT (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:05 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
5:10 AM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Freebird Investments LLC (Reporting)
Freebird Partners LP (Reporting)
HUFF CURTIS W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
5:02 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2023
3:30 PM | BINDER BRANT (Reporting)
NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
3:31 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
WAGNER RICHARD W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
3:15 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
7:30 PM | NTN Buzztime (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:32 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
3:34 PM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
6:00 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form DEF 14A | |
05/05/2023
6:01 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form DEFA14A | |
05/05/2023
6:01 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form ARS | |
The AI stock to buy right now (Ad) There are about 350,000 large corporations worldwide.
Can you see the potential for this AI company to grow like crazy? Click Here to Get the AI Stock Name |
05/05/2023
5:30 AM | NTN Buzztime (Filer)
Eterna Therapeutics Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
